1 Ultra-Elite Dividend Stock to Buy Hand Over Fist in June
Johnson Johnson (NYSE: JNJ) is one of the best dividend stocks on the planet. The healthcare behemoth has increased its dividend each year for over six decades, putting it in the super-elite class of dividend Kings. The company currently offers a roughly 3% dividend yield, which is almost double that of an S 500 Index Fund (recently around 1.6%). That highly attractive payout is on an extremely safe foundation.
The company's dividend yield is approaching its highest level since the early days of the pandemic and at the higher end of its range over the past decade. Meanwhile, the company is about to spin off shares of its consumer healthcare business, Kenvue (NYSE: KVUE), to shareholders, giving them another attractive income producer. These factors make Johnson & Johnson stock one income investors should buy hand over fist this June.
Johnson Johnson is a financial fortress. The healthcare behemoth has a AAA bond rating, which is higher than the U.S. Government. While that might not be saying much these days, the healthcare giant's credit is tied with Microsoft for the best globally.
Source Fool.com
Microsoft Corp. Aktie
Microsoft Corp. sticht hervor mit 109 Buy- und nur 2 Sell-Einschätzungen.
Das von der Community festgelegte Kursziel von 426 € für Microsoft Corp. deutet auf ein leichtes Wachstumspotenzial im Vergleich zu 379.6 € hin.
